Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' HOELZER D' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 303 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Moller, B; Kukoc-Zivojnov, N; Kessler, U; Rehart, S; Kaltwasser, JP; Hoelzer, D; Kalina, U; Ottmann, OG
      Expression of interleukin-18 and its monokine-directed function in rheumatoid arthritis

      RHEUMATOLOGY
    2. Rossmanith, T; Schroder, B; Bug, G; Muller, P; Klenner, T; Knaus, R; Hoelzer, D; Ottmann, OG
      Interleukin 3 improves the ex vivo expansion of primitive human cord bloodprogenitor cells and maintains the engraftment potential of SCID repopulating cells

      STEM CELLS
    3. Chow, KU; Mitrou, PS; Geduldig, K; Helm, EB; Hoelzer, D; Brodt, HR
      Changing incidence and survival in patients with AIDS-related non-Hodgkin's lymphomas in the era of highly active antiretroviral therapy (HAART)

      LEUKEMIA & LYMPHOMA
    4. Seipelt, G; Bohme, A; Koschmieder, S; Hoelzer, D
      Effective treatment with rituximab in a patient with refractory prolymphocytoid transformed B-chronic lymphocytic leukemia and Evans syndrome

      ANNALS OF HEMATOLOGY
    5. Koschmieder, S; Bug, G; Schroder, B; Rossmanith, T; Hofmann, WK; Kalina, U; Hoelzer, D; Ottmann, OG
      Murine M2-10B4 and SL/SL cell lines differentially affect the balance between CD34(+) cell expansion and maturation

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    6. Kantarjian, HM; Hoelzer, D; Larson, RA
      Advances in the treatment of adult acute lymphocytic leukemia, part II - Preface

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    7. Koschmieder, S; Hofmann, WK; Kunert, J; Wagner, S; Ballas, K; Seipelt, G; Hoelzer, D; Ottmann, OG; Kalina, U
      TGF beta-induced SMAD2 phosphorylation predicts inhibition of thymidine incorporation in CD34(+) cells from healthy donors, but not from patients with AML after MDS

      LEUKEMIA
    8. Chow, KU; Boehrer, S; Geduldig, K; Krapohl, A; Hoelzer, D; Mitrou, PS; Weidmann, E
      In vitro induction of apoptosis of neoplastic cells in low-grade non-Hodgkin's lymphomas using combinations of established cytotoxic drugs with bendamustine

      HAEMATOLOGICA
    9. Weidmann, E; Boehrer, S; Chow, KU; Engels, K; Harder, L; Hinz, T; Janssen, O; Kriener, S; Rummel, MJ; Siebert, R; Kabelitz, D; Hansmann, ML; Hoelzer, D; Mitrou, PS
      Treatment of aggressive, or progressing indolent peripheral T- and NK-cellneoplasias by combination of fludarabine, cyclophosphamide and doxorubicine

      ONKOLOGIE
    10. Kalina, U; Koschmieder, S; Hofmann, WK; Wagner, S; Kauschat, D; Hoelzer, D; Ottmann, OG
      Transforming growth factor-beta(1) interferes with thrombopoietin-induced signal transduction in megakaryoblastic and erythroleukemic cells

      EXPERIMENTAL HEMATOLOGY
    11. Mahlknecht, U; Schnittger, S; Landgraf, F; Schoch, C; Ottmann, OG; Hiddemann, W; Hoelzer, D
      Assignment of the human histone deacetylase 6 gene (HDAC6) to X chromosomep11.23 by in situ hybridization

      CYTOGENETICS AND CELL GENETICS
    12. Mahlknecht, U; Schnittger, S; Hoelzer, D
      Assignment of the human histone deacetylase 4 gene (HDAC4) to chromosome 2q37.2 by in situ hybridization

      CYTOGENETICS AND CELL GENETICS
    13. Wassmann, B; Klein, SA; Scheuring, U; Pfeifer, H; Martin, H; Gschaidmeier, H; Hoelzer, D; Ottmann, OG
      Hematologic and cytogenetic remission by STI571 (Glivec) in a patient relapsing with accelerated phase CML after second allogeneic stem cell transplantation

      BONE MARROW TRANSPLANTATION
    14. Seidl, C; Korbitzer, J; Badenhoop, K; Seifried, E; Hoelzer, D; Zanelli, E; Kaltwasser, JP
      Protection against severe disease is conferred by DERAA-bearing HLA-DRB1 alleles among HLA-DQ3 and HLA-DQ5 positive rheumatoid arthritis patients

      HUMAN IMMUNOLOGY
    15. Mahlknecht, U; Ottmann, OG; Hoelzer, D
      Far-Western based protein-protein interaction screening of high-density protein filter arrays

      JOURNAL OF BIOTECHNOLOGY
    16. Hofmann, WK; Miller, CW; Tsukasaki, K; Tavor, S; Ikezoe, T; Hoelzer, D; Takeuchi, S; Koeffler, HP
      Mutation analysis of the DNA-damage checkpoint gene CHK2 in myelodysplastic syndromes and acute myeloid leukemias

      LEUKEMIA RESEARCH
    17. Fauth, F; Weidmann, E; Martin, H; Schneider, B; Sonnhoff, S; Hoelzer, D
      AC133 expression on acute myeloid leukemia blasts: correlation to FAB and to CD34 expression and possible implications for peripheral blood progenitor cell purging in AML

      LEUKEMIA RESEARCH
    18. Hofmann, WK; Takeuchi, S; Xie, D; Miller, CW; Hoelzer, D; Koeffler, HP
      Frequent loss of heterozygosity in the region of D1S450 at 1p36.2 in myelodysplastic syndromes

      LEUKEMIA RESEARCH
    19. Hermann, S; Klein, SA; Jacobi, V; Thalhammer, A; Bialleck, H; Duchscherer, M; Wassmann, E; Hoelzer, D; Martin, H
      Older patients with high-risk fungal infections can be successfully allografted using non-myeloablative conditioning in combination with intensified supportive care regimens

      BRITISH JOURNAL OF HAEMATOLOGY
    20. Boehrer, S; Hinz, T; Schui, DK; Harder, S; Chow, KU; Schneider, B; Hoelzer, D; Mitrou, PS; Weidmann, E
      T-large granular lymphocyte leukaemia with natural killer cell-like cytotoxicity and expression of two different alpha- and beta-T-cell receptor chains

      BRITISH JOURNAL OF HAEMATOLOGY
    21. Schui, DK; Singh, L; Krapohl, A; Schneider, B; Hoelzer, D; Weidmann, E
      Dendritic cells from AML patients in complete remission are capable to present antigen to autologous T lymphocytes

      ACUTE LEUKEMIAS VIII: PROGNOSTIC FACTORS AND TREATMENT STRATEGIES
    22. Vogl, TJ; Hinrichs, T; Jacobi, V; Bohme, A; Hoelzer, D
      Computed tomographic appearance of mucormycosis.

      ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN
    23. Klein, SA; Klebba, C; Kauschat, D; Pape, M; Ozmen, L; Hoelzer, D; Ottmann, OG; Kalina, U
      Interleukin-18 stimulates HIV-1 replication in a T-cell line

      EUROPEAN CYTOKINE NETWORK
    24. Mahlknecht, U; Hoelzer, D
      Histone acetylation modifiers in the pathogenesis of malignant disease

      MOLECULAR MEDICINE
    25. Seipelt, G; Ottmann, OG; Hoelzer, D
      Cytokine therapy for myelodysplastic syndrome

      CURRENT OPINION IN HEMATOLOGY
    26. Hofmann, WK; Kalina, U; Koschmieder, S; Seipelt, G; Hoelzer, D; Ottmann, OG
      Defective megakaryocytic development in myelodysplastic syndromes

      LEUKEMIA & LYMPHOMA
    27. Chow, KU; Rummel, MJ; Weidmann, E; Ries, J; Jantschke, P; Boehrer, S; Pourebrahim, F; Napieralski, S; Stein, J; Martin, H; Hoelzer, D; Mitrou, PS
      Induction of apoptosis by 2-chloro-2 ' deoxyadenosine (2-CdA) alone and incombination with other cytotoxic drugs: Synergistic effects on normal and neoplastic lymphocytes by addition of doxorubicin and mitoxantrone

      LEUKEMIA & LYMPHOMA
    28. Hoelzer, D; Gokbuget, N
      Recent approaches in acute lymphoblastic leukemia in adults

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    29. Klebba, C; Ottmann, OG; Scherr, M; Pape, M; Engels, JW; Grez, M; Hoelzer, D; Klein, SA
      Retrovirally expressed anti-HIV ribozymes confer a selective survival advantage on CD4(+) T cells in vitro

      GENE THERAPY
    30. Gottschalk, R; Seidl, C; Schilling, S; Braner, A; Seifried, E; Hoelzer, D; Kaltwasser, JP
      Iron-overload and genotypic expression of HFE mutations H63D/C282Y and transferrin receptor Hin6I and BanI polymorphism in German patients with hereditary haemochromatosis

      EUROPEAN JOURNAL OF IMMUNOGENETICS
    31. Chow, KU; Ries, J; Weidmann, E; Pourebrahim, F; Napieralski, S; Stieler, M; Boehrer, S; Rummel, MJ; Stein, J; Hoelzer, D; Mitrou, PS
      Induction of apoptosis using 2 ',2 ' difluorodeoxycytidine (gemcitabine) in combination with antimetabolites or anthracyclines on malignant lymphaticand myeloid cells. Antagonism or synergism depends on incubation schedule and origin of neoplastic cells

      ANNALS OF HEMATOLOGY
    32. Hofmann, WK; Seipelt, G; Ottmann, OG; Kalina, U; Koschmieder, S; Brucher, J; Frickhofen, N; Klausmann, M; Mitrou, PS; Hoelzer, D
      Effect of treatment with amifostine used as a single agent in patients with refractory anemia on clinical outcome and serum tumor necrosis factor alpha levels

      ANNALS OF HEMATOLOGY
    33. Ganser, A; Heil, G; Seipelt, G; Hofmann, W; Fischer, JT; Langer, W; Brockhaus, W; Kolbe, K; Ittel, H; Brack, N; Fuhr, HG; Knuth, P; Hoffken, K; Bergmann, L; Hoelzer, D
      Intensive chemotherapy with idarubicin, ara-C, etoposide, and m-AMSA followed by immunotherapy with interleukin-2 for myelodysplastic syndromes and high-risk Acute Myeloid Leukemia (AML)

      ANNALS OF HEMATOLOGY
    34. Mahlknecht, U; Ottmann, OG; Hoelzer, D
      When the band begins to play: Histone acetylation caught in the crossfire of gene control

      MOLECULAR CARCINOGENESIS
    35. Gokbuget, N; Hoelzer, D; Arnold, R; Bohme, A; Bartram, CR; Freund, M; Ganser, A; Kneba, M; Langer, W; Lipp, T; Ludwig, WD; Maschmeyer, G; Rieder, H; Thiel, E; Weiss, A; Messerer, D
      Treatment of adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL)

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    36. Kantarjian, HM; Hoelzer, D; Larson, RA
      Advances in the treatment of adult acute lymphocytic leukemia, part I - Preface

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    37. Hofmann, WK; Kell, WJ; Fenaux, P; Castaigne, S; Ganser, A; Chomienne, C; Burnett, R; Kowal, C; Hoelzer, D; Burnett, AK
      Oral 9-cis retinoic acid (Alitretinoin) in the treatment of myelodysplastic syndromes: results from a pilot study

      LEUKEMIA
    38. Xie, D; Hofmann, WK; Mori, N; Miller, CW; Hoelzer, D; Koeffler, HP
      Allelotype analysis of the myelodysplastic syndrome

      LEUKEMIA
    39. Weidmann, E; Hinz, T; Klein, S; Schui, DK; Harder, S; Kriener, S; Kabelitz, D; Hoelzer, D; Mitrou, PS
      Cytotoxic hepatosplenic gamma delta T-cell lymphoma following acute myeloid leukemia bearing two distinct gamma chains of the T-cell receptor. Biological and clinical features

      HAEMATOLOGICA
    40. Bohme, A; Hoelzer, D
      Primary antifungal prophylaxis with low-dose intravenous amphotericin B inhematological malignancies. Results of a pilot study

      ONKOLOGIE
    41. Hofmann, WK; Seipelt, G; Kalina, U; Hoelzer, D
      New aspects of the treatment of patients with low-risk myelodysplastic syndromes

      ONKOLOGIE
    42. Kalina, U; Hofmann, WK; Koschmieder, S; Wagner, S; Kauschat, D; Hoelzer, D; Ottmann, OG
      Alteration of c-mpl-mediated signal transduction in CD34(+) cells from patients with myelodysplastic syndromes

      EXPERIMENTAL HEMATOLOGY
    43. Kalina, U; Ballas, K; Koyama, N; Kauschat, D; Miething, C; Arnemann, J; Martin, H; Hoelzer, D; Ottmann, OG
      Genomic organization and regulation of the human interleukin-18 gene

      SCANDINAVIAN JOURNAL OF IMMUNOLOGY
    44. Fauth, F; Martin, H; Sonnhoff, S; Bialleck, H; Wiesneth, M; Mihanovic, B; Hoelzer, D
      Purging of G-CSF-mobilized peripheral autografts in acute leukemia with mafosfamide and amifostine to protect normal progenitor cells

      BONE MARROW TRANSPLANTATION
    45. Atta, J; Fauth, F; Keyser, M; Petershofen, E; Weber, C; Lippok, G; Hoelzer, D; Martin, H
      Purging in BCR-ABL-positive acute lymphoblastic leukemia using immunomagnetic beads: comparison of residual leukemia and purging efficiency in bone marrow vs peripheral blood stem cells by semiquantitative polymerase chain reaction

      BONE MARROW TRANSPLANTATION
    46. Grez, M; Becker, S; Saulnier, S; Knoss, H; Ott, MG; Maurer, A; Dinauer, MC; Hoelzer, D; Seger, R; Hossle, JP
      Gene therapy of chronic granulomatous disease

      BONE MARROW TRANSPLANTATION
    47. Mahlknecht, U; Schnittger, S; Ottmann, OG; Schoch, C; Mosebach, M; Hiddemann, W; Hoelzer, D
      Chromosomal organization and localization of the human histone deacetylase5 gene (HDAC5)

      BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION
    48. Hoelzer, D; Gokbuget, N
      New approaches to acute lymphoblastic leukemia in adults: Where do we go?

      SEMINARS IN ONCOLOGY
    49. Bohme, A; Karthaus, M; Hoelzer, D
      Antifungal prophylaxis in neutropenic patients with hematologic malignancies

      SUPPORTIVE CARE IN CANCER PATIENTS: RECENT DEVELOPMENTS
    50. Seidl, C; Siehl, J; Ganser, A; Hofmann, WK; Fischer, M; Kirchmaier, CM; Hoelzer, D; Seifried, E
      Platelet glycoprotein expression in patients with myelodysplastic syndrome

      THROMBOSIS RESEARCH
    51. Kalina, U; Kauschat, D; Koyama, N; Nuernberger, H; Ballas, K; Koschmieder, S; Bug, G; Hofmann, WK; Hoelzer, D; Ottmann, OG
      IL-18 activates STAT3 in the natural killer cell line 92, augments cytotoxic activity, and mediates IFN-gamma production by the stress kinase p38 andby the extracellular regulated kinases p44(erk-1) and p42(erk-21)

      JOURNAL OF IMMUNOLOGY
    52. Wassmann, B; Seipelt, G; Langer, F; Rummel, M; Bohme, A; Hansmann, ML; Hoelzer, D
      Reactive hemophagocytic syndrome with involvement of the spleen, splenic-hilum lymph nodes, bone marrow and the liver

      INTERNIST
    53. Gottschalk, R; Wigand, R; Dietrich, CF; Oremek, G; Liebisch, F; Hoelzer, D; Kaltwasser, JP
      Total iron-binding capacity and serum transferrin determination under the influence of several clinical conditions

      CLINICA CHIMICA ACTA
    54. Puccetti, E; Guller, S; Orleth, A; Bruggenolte, N; Hoelzer, D; Ottmann, OG; Ruthardt, M
      BCR-ABL mediates arsenic trioxide-induced apoptosis independently of its aberrant kinase activity

      CANCER RESEARCH
    55. Klein, SA; Klebba, C; Hoelzer, D; Grez, M
      Gene therapy of HIV infection

      ANTIVIRALS AGAINST AIDS
    56. Klein, SA; Ottmann, OG; Ballas, K; Dobmeyer, TS; Pape, M; Weidmann, E; Hoelzer, D; Kalina, U
      Quantification of human interleukin 18 mRNA expression by competitive reverse transcriptase polymerase chain reaction

      CYTOKINE
    57. Rummel, MJ; Chow, KU; Jager, E; Leimer, L; Hossfeld, DK; Bergmann, L; Peters, HD; Hansmann, ML; Meyer, A; Hoelzer, D; Mitrou, PS
      Intermittent 2-hour-infusion of cladribine as first-line therapy or in first relapse of progressive advanced low-grade and mantle cell lymphomas

      LEUKEMIA & LYMPHOMA
    58. Weidmann, E; Baican, B; Hertel, A; Baum, RP; Chow, KU; Knupp, B; Adams, S; Hor, G; Hoelzer, D; Mitrou, PS
      Positron emission tomography (PET) for staging and evaluation of response to treatment in patients with Hodgkin's disease

      LEUKEMIA & LYMPHOMA
    59. Krauter, J; Ganser, A; Bergmann, L; Raghavachar, A; Hoelzer, D; Lubbert, M; Schlimok, G; Arnold, R; Kirchner, H; Port, M; Heil, G
      Association between structural and numerical chromosomal aberrations in acute myeloblastic leukemia: a study by RT-PCR and FISH in 447 patients with de-novo AML

      ANNALS OF HEMATOLOGY
    60. Hofmann, WK; Ganser, A; Seipelt, G; Ottmann, OG; Zander, C; Geissler, G; Hoffmann, K; Hoffken, K; Fischer, JT; Isele, G; Hoelzer, D
      Treatment of patients with low-risk myelodysplastic syndromes using a combination of all-trans retinoic acid, interferon alpha, and granulocyte colony-stimulating factor

      ANNALS OF HEMATOLOGY
    61. Rummel, MJ; Kafer, G; Pfreundschuh, M; Jager, E; Reinhardt, U; Mitrou, PS; Hoelzer, D; Bergmann, L
      Fludarabine and epirubicin in the treatment of chronic lymphocytic leukaemia: A German multicenter phase II study

      ANNALS OF ONCOLOGY
    62. Rummel, MJ; Chow, KU; Jager, E; Hossfeld, DK; Bergmann, L; Peters, HD; Hansmann, ML; Meyer, A; Hoelzer, D; Mitrou, PS
      Treatment of mantle-cell lymphomas with intermittent two-hour infusion of cladribine as first-line therapy or in first relapse

      ANNALS OF ONCOLOGY
    63. Hofmann, WK; Kalina, U; Seipelt, G; Hoffmann, K; Wagner, S; Hoelzer, D; Ottmann, OG
      Megakaryocytic growth in patients with refractory anemia is suppressed by treatment with interferon alpha

      EUROPEAN JOURNAL OF HAEMATOLOGY
    64. Ottmann, OG; Hoelzer, D; Hofmann, WK
      Clinical use of thrombopoietin

      LEUKEMIA
    65. Hofmann, WK; Ottmann, OG; Hoelzer, D
      Megakaryocytic growth factors: is there a new approach for management of thrombocytopenia in patients with malignancies?

      LEUKEMIA
    66. Hofmann, WK; Ottmann, OG; Hoelzer, D
      Megakaryocytic growth factors: is there a new approach for management of thrombocytopenia in patients with malignancies?

      LEUKEMIA
    67. Mahlknecht, U; Hoelzer, D; Bucala, R
      Sequencing of genomic DNA

      BIOTECHNIQUES
    68. Hofmann, WK; Kalina, U; Wagner, S; Seipelt, G; Ries, C; Hoelzer, D; Ottmann, OG
      Characterization of defective megakaryocytic development in patients with myelodysplastic syndromes

      EXPERIMENTAL HEMATOLOGY
    69. Mahlknecht, U; Bucala, R; Hoelzer, D; Verdin, E
      High resolution physical mapping of human HDAC3, a potential tumor suppressor gene in the 5q31 region

      CYTOGENETICS AND CELL GENETICS
    70. Sternsdorf, T; Puccetti, E; Jensen, K; Hoelzer, D; Will, H; Ottmann, OG; Ruthardt, M
      PIC-1/SUMO-1-modified PML-retinoic acid receptor alpha mediates arsenic trioxide-induced apoptosis in acute promyelocytic leukemia

      MOLECULAR AND CELLULAR BIOLOGY
    71. Bohme, A; Karthaus, M; Hoelzer, D
      Antifungal prophylaxis in neutropenic patients with hematologic malignancies: Is there a real benefit?

      CHEMOTHERAPY
    72. Archimbaud, E; Ottmann, OG; Yin, JAL; Lechner, K; Dombret, H; Sanz, MA; Heil, G; Fenaux, P; Brugger, W; Barge, A; O'Brien-Ewen, C; Matcham, J; Hoelzer, D
      A randomized, double-blind, placebo-controlled study with pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) as anadjunct to chemotherapy for adults with de novo acute myeloid leukemia

      BLOOD
    73. Mahlknecht, U; Hoelzer, D; Bucala, R; Verdin, E
      Cloning and characterization of the murine histone deacetylase (HDAC3)

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    74. Hoelzer, D
      Acute lymphoblastic leukaemia in adults

      TEXTBOOK OF MALIGNANT HAEMATOLOGY
    75. KALINA U; KLEBBA C; KAUSCHAT D; PAPE M; HOELZER D; OTTMANN OG; KLEIN SA
      HIV-1 REPLICATION IS ENHANCED BY PRO- AND EUKARYOTICALLY EXPRESSED RECOMBINANT INTERLEUKIN-18

      European cytokine network
    76. KAUSCHAT D; KOYAMA N; BUG G; HOELZER D; OTTMANN OG; KALINA U
      SIGNAL-TRANSDUCTION IN THE NATURAL-KILLER-CELL LINE NK-92 INDUCED BY INTERLEUKIN-18 INVOLVES TYROSINE PHOSPHORYLATION OF STAT3 AND MAP KINASE

      European cytokine network
    77. BECKER S; WASSER S; HAUSES M; HOSSLE JP; OTT MG; DINAUER MC; GANSER A; HOELZER D; SEGER R; GREZ M
      CORRECTION OF RESPIRATORY BURST ACTIVITY IN X-LINKED CHRONIC GRANULOMATOUS CELLS TO THERAPEUTICALLY RELEVANT LEVELS AFTER GENE-TRANSFER INTO BONE-MARROW CD34(+) CELLS

      Human gene therapy
    78. HOELZER D
      OVERVIEW OF CHEMOTHERAPY FOR ALL

      Leukemia & lymphoma (Print)
    79. SEIPELT G; HOFMANN WK; MARTIN H; WASSMANN B; BOEHME A; OTTMANN OG; HOELZER D
      COMPARISON OF TOXICITY AND OUTCOME IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA TREATED WITH HIGH-DOSE CYTOSINE-ARABINOSIDE CONSOLIDATION AFTER INDUCTION WITH A REGIMEN CONTAINING IDARUBICIN OR DAUNORUBICIN

      Annals of hematology
    80. Bohme, A; Wolter, M; Hoelzer, D
      L-tryptophan-related eosinophilia-myalgia syndrome possibly associated with a chronic B-lymphocytic leukemia

      ANNALS OF HEMATOLOGY
    81. KARAKAS T; MAURER U; WEIDMANN E; MIETHING CC; HOELZER D; BERGMANN L
      HIGH EXPRESSION OF BCL-2 MESSENGER-RNA AS A DETERMINANT OF POOR-PROGNOSIS IN ACUTE MYELOID-LEUKEMIA

      Annals of oncology
    82. RUMMEL M; KNUTH A; HOSSFELD D; BERGMANN L; HOELZER D; MITROU PS
      2-CDA IN THE TREATMENT OF PREVIOUSLY UNTREATED LOW-GRADE NON-HODGKINS-LYMPHOMAS - FINAL RESULTS

      Annals of oncology
    83. RIEDER H; BONWETSCH C; JANSSEN LAJ; MAURER J; JANSSEN JWG; SCHWARTZ S; LUDWIG WD; GASSMANN W; BARTRAM CR; THIEL E; LOFFLER H; GOKBUGET N; HOELZER D; FONATSCH C
      HIGH-RATE OF CHROMOSOME-ABNORMALITIES DETECTED BY FLUORESCENCE IN-SITU HYBRIDIZATION USING BCR AND ABL PROBES IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA

      Leukemia
    84. WEIDMANN E; SCHUI DK; SINGH L; HOELZER D
      ESTABLISHMENT OF DENDRITIC CELLS USING PERIPHERAL MONOCYTES FROM PATIENTS WITH AML IN COMPLETE REMISSION FOLLOWING CHEMOTHERAPY

      Journal of leukocyte biology
    85. BUG G; SCHRODER B; KOSCHMIEDER S; BISELLI M; HOELZER D; OTTMANN OG
      EXPANSION OF HUMAN HEMATOPOIETIC STEM-CELLS - UPSCALING OF CULTURE CONDITIONS

      Experimental hematology
    86. KOSCHMIEDER S; SCHRODER B; BUG G; BISELLI M; HOELZER D; OTTMANN OG
      STROMA-BASED EXPANSION OF CD34-BED BIOREACTOR( CELLS FOR USE IN A CONTINUOUSLY PERFUSED PACKED)

      Experimental hematology
    87. HOFMANN WK; KALINA U; WAGNER S; HOELZER D; OTTMANN OG
      ANALYSIS OF THE THROMBOPOIETIN-RECEPTOR IN CD34-LENGTH RT-PCR( CELLS FROM PATIENTS WITH MYELODYSPLASTIC SYNDROMES USING A FULL)

      Experimental hematology
    88. KALINA U; HOFMANN WK; WAGNER S; HOELZER D; OTTMANN OG
      SIGNAL-TRANSDUCTION OF C-MPL RECEPTOR IN CD34+ CELLS FROM PATIENTS WITH MYELODYSPLASTIC SYNDROMES

      Experimental hematology
    89. HOHAUS S; MARTIN H; WASSMANN B; EGERER G; HAUS U; FARBER L; BURGER KJ; GOLDSCHMIDT H; HOELZER D; HAAS R
      RECOMBINANT HUMAN GRANULOCYTE AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (G-CSF AND GM-CSF) ADMINISTERED FOLLOWING CYTOTOXIC CHEMOTHERAPY HAVE A SIMILAR ABILITY TO MOBILIZE PERIPHERAL-BLOOD STEM-CELLS

      Bone marrow transplantation
    90. FREUND M; HEIL G; ARNOLD R; BALLEISEN L; BUCHNER T; DIEDRICH H; EIMERMACHER H; FONATSCH C; GANSER A; GASSMANN W; HARTMANN F; HIDDEMANN W; KASPER C; KNAUF WU; KOCH P; KUBICA U; LINK H; LOFFLER H; LUDWIG WD; MASCHMEYER G; POMPE K; SCHADECK C; SCHMITZ N; SCHONROCKNABULSI P; SCHWONZEN M; THIEL E; WEISS A; HOELZER D
      THE ROLE OF BONE-MARROW TRANSPLANTATION AND HIGH-DOSE CHEMOTHERAPY INRELAPSING ACUTE LYMPHOCYTIC-LEUKEMIA

      Bone marrow transplantation
    91. PASSWEG JR; TIBERGHIEN P; CAHN JY; VOWELS MR; CAMITTA BM; GALE RP; HERZIG RH; HOELZER D; HOROWITZ MM; IFRAH N; KLEIN JP; MARKS DI; RAMSAY NKC; ROWLINGS PA; WEISDORF DJ; ZHANG MJ; BARRETT AJ
      GRAFT-VERSUS-LEUKEMIA EFFECTS IN T-LINEAGE AND B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA

      Bone marrow transplantation
    92. ARNOLD R; BUNJES D; DEEG HJ; EINSELE H; FAUSER AA; FINKE J; HERTENSTEIN B; HEYLL A; KOLB HJ; KOLBE K; MARTIN H; NIEDERWIESER D; SCHAEFER UW; SCHMITZ N; SCHWERDTFEGER R; SIEGERT W; WANDT H; ZANDER A; GOEKBUGET N; HOELZER D
      BMT IN REFRACTORY OR RELAPSED ADULT ALL PATIENTS TREATED IN THE GERMAN MULTICENTER ALL STUDIES

      Bone marrow transplantation
    93. FAUTH F; MARTIN H; RODE C; ATTA J; HOELZER D
      DOSE-ADAPTED MAFOSFAMIDE-PURGING WITH AMIFOSTINE OF G-CSF-MOBILIZED PERIPHERAL-BLOOD AUTOGRAFTS IN ACUTE-LEUKEMIA

      Bone marrow transplantation
    94. MARTIN H; ATTA J; FAUTH F; OTTMANN OG; OTT MG; WASSMANN B; BERGMANN L; KNAUF W; GRAMATZKI M; ZANDER A; BUNJES D; ARNOLD R; HOELZER D
      AUTOLOGOUS BMT PBSCT IN PATIENTS WITH BCR-ABL-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA/

      Bone marrow transplantation
    95. GOLDSCHMIDT H; MARTIN H; HEGENBART U; KO Y; GLASMACHER A; GERHARTZ H; HANEL A; RUDOLPH C; WILHELM M; GIESELER F; BORNHAUSER M; EHNINGER G; HOELZER D; HUHN D; HAAS R
      TANDEM AUTOLOGOUS TRANSPLANTATION (TPX) FOR MULTIPLE-MYELOMA - FIRST RESULTS OF A GERMAN MULTICENTER STUDY

      Bone marrow transplantation
    96. VELDMAN A; MARTIN H; FAUTH F; POTZSCH B; SCHARRER I; ETTINGSHAUSEN CE; HOELZER D; KREUZ W; GOETHE JW
      A NEW OPTION IN THE TREATMENT OF VOD AFTER BMT - CONTINUOUS-INFUSION OF RECOMBINANT TISSUE-PLASMINOGEN ACTIVATOR AND PROTEIN-C

      Bone marrow transplantation
    97. GOKBUGET N; HOELZER D
      MENINGEOSIS LEUKAEMICA IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA

      Journal of neuro-oncology
    98. RIEDER H; REHDER H; BURKERT M; SCHONBERGER B; HOELZER D
      FURTHER EVIDENCE FOR AN EXTRA Y-CHROMOSOME TO REPRESENT A NEW PRIMARYCHROMOSOME ABNORMALITY IN IMMATURE T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA

      Cancer genetics and cytogenetics
    99. BOHME A; SHAH PM; STILLE W; HOELZER D
      PROSPECTIVE RANDOMIZED STUDY TO COMPARE IMIPENEM 1.5 GRAMS PER DAY VS. 3.0 GRAMS PER DAY IN INFECTIONS OF GRANULOCYTOPENIC PATIENTS

      The Journal of infection
    100. SCHILZ AJ; BROUNS G; KNOSS H; OTTMANN O; HOELZER D; FAUSER AA; THRASHER A; GREZ M
      EFFICIENT GENE-TRANSFER TO HUMAN REPOPULATING CELLS

      Molecular immunology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/10/20 alle ore 03:31:39